Bank of New York Mellon’s Atossa Therapeutics ATOS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.25K | Sell |
11,147
-278,580
| -96% | -$231K | ﹤0.01% | 4108 |
|
|
2025
Q1 | $195K | Hold |
289,727
| – | – | ﹤0.01% | 3872 |
|
|
2024
Q4 | $274K | Sell |
289,727
-13,922
| -5% | -$13.1K | ﹤0.01% | 3806 |
|
|
2024
Q3 | $462K | Sell |
303,649
-108,018
| -26% | -$164K | ﹤0.01% | 3556 |
|
|
2024
Q2 | $490K | Buy |
411,667
+399,041
| +3,160% | +$475K | ﹤0.01% | 3587 |
|
|
2024
Q1 | $22.7K | Sell |
12,626
-39,591
| -76% | -$71.3K | ﹤0.01% | 4102 |
|
|
2023
Q4 | $46K | Sell |
52,217
-58,631
| -53% | -$51.6K | ﹤0.01% | 4157 |
|
|
2023
Q3 | $81.6K | Sell |
110,848
-1,808
| -2% | -$1.33K | ﹤0.01% | 4102 |
|
|
2023
Q2 | $142K | Sell |
112,656
-38,624
| -26% | -$48.7K | ﹤0.01% | 4033 |
|
|
2023
Q1 | $110K | Hold |
151,280
| – | – | ﹤0.01% | 4055 |
|
|
2022
Q4 | $80K | Sell |
151,280
-772
| -0.5% | -$408 | ﹤0.01% | 4160 |
|
|
2022
Q3 | $127K | Hold |
152,052
| – | – | ﹤0.01% | 4151 |
|
|
2022
Q2 | $166K | Sell |
152,052
-358,488
| -70% | -$391K | ﹤0.01% | 4118 |
|
|
2022
Q1 | $639K | Sell |
510,540
-9,118
| -2% | -$11.4K | ﹤0.01% | 3567 |
|
|
2021
Q4 | $832K | Buy |
519,658
+42,367
| +9% | +$67.8K | ﹤0.01% | 3488 |
|
|
2021
Q3 | $1.56M | Buy |
477,291
+11,719
| +3% | +$38.2K | ﹤0.01% | 3140 |
|
|
2021
Q2 | $2.94M | Buy |
465,572
+429,645
| +1,196% | +$2.72M | ﹤0.01% | 2759 |
|
|
2021
Q1 | $76K | Buy |
+35,927
| New | +$76K | ﹤0.01% | 4195 |
|
|
2018
Q2 | – | Sell |
-18,759
| Closed | -$8K | – | 4201 |
|
|
2018
Q1 | $8K | Buy |
+18,759
| New | +$8K | ﹤0.01% | 4280 |
|